Global Pharmaceutical Contract Development and Manufacturing Market Size, Status and Forecast 2020-2026

Report Description


The Global Pharmaceutical Contract Development and Manufacturing Market Report provides Insightful information to the clients enhancing their basic leadership capacity identified with the global Pharmaceutical Contract Development and Manufacturing Market business, including market dynamics, segmentation, competition, and regional growth. The strategy of expansion has been adopted by key players who are increasing their production capacities to cater to the increasing demand for various application.

New traders at intervals the Pharmaceutical Contract Development and Manufacturing Market face strong competition from ancient world traders as they try with technological revolutions, dependableness and commonplace of Pharmaceutical Contract Development and Manufacturing Market product affairs. The report is at risk of project regarding this Pharmaceutical Contract Development and Manufacturing Market evolutions and additionally the magnitude of competition, value and extra.

Leading market players: (Option 1: Free 25% Customization Profiles of 5 Additional Companies of your Choice)


This business intelligence report offers profiling of reputed companies that are operating in the market. Companies such as:

  • Thermo Fisher Scientific Inc.
  • Catalent, Inc.
  • Lonza Group Ltd
  • Recipharm AB
  • Vetter Pharma International GMBH
  • FAMAR Health Care Services
  • AbbVie Inc.
  • Aenova Group
  • Consort Medical plc
  • Almac Group
  • Siegfried Holding AG
  • Boehringer Ingelheim International GmbH
  • Evonik Industries AG

Others players have been profiled into detail so as to offer a glimpse of the market leaders. Moreover, parameters such as Pharmaceutical Contract Development and Manufacturing related investment & spending and developments by major players of the market are tracked in this Global report.

Years considered for the study:


Pharmaceutical Contract Development and Manufacturing Market

Pharmaceutical Contract Development and Manufacturing Market

Report Highlights:


The Pharmaceutical Contract Development and Manufacturing Market is widely partitioned reliant on the predictable updates in the enhancement of parameters for example, quality, trustworthiness, end customer solicitations, applications, and others. The Pharmaceutical Contract Development and Manufacturing Market report contains general successful parameters, confinements, and besides has in detail illumination of the noteworthy data close by the present and future examples that may concern the advancement. The comprehensive Pharmaceutical Contract Development and Manufacturing Market report elucidates within and outside representation of current advancements, parameters, and establishments.

The key regions analyzed in this study include North America, Europe, Japan, China, India, Korea, South East Asia, South America, Middle East and African countries. The leading players of Pharmaceutical Contract Development and Manufacturing Market and their geographical presence across the globe are estimated based on production capacity, utilization ratio, consumer base, demand and supply scenario, profit margin and Pharmaceutical Contract Development and Manufacturing marketers.

Data Lab Forecast performed primary as well as exhaustive secondary research for this study. We conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, DLF was able to include manufacturers that could not be identified due to the limitations of secondary research. We analysed product offerings, distribution channel and regional presence of all major companies in the industry.

Data Lab Forecast calculated the market size for the Pharmaceutical Contract Development and Manufacturing market using a bottom-up approach, wherein manufacturers value data for different type (Pharmaceutical Manufacturing Services, Biologics Manufacturing Services, Drug Development Services), of Pharmaceutical Contract Development and Manufacturing market was recorded as well as forecast for the future years was made. Data Lab Forecast sourced these values from industry experts and company representatives, and externally validated through analyzing historical sales data of respective manufacturers to arrive at the overall market size. Various secondary sources such as company annual reports, white papers, investor presentations and financial reports were also studied by Data Lab Forecast.

Pharmaceutical Contract Development and Manufacturing Market

Pharmaceutical Contract Development and Manufacturing Market

Key Target Audience:


  • Pharmaceutical Contract Development and Manufacturing market companies.
  • Research organizations and consulting companies.
  • Organizations, associations and alliances related to the Pharmaceutical Contract Development and Manufacturing market industry.
  • Government bodies such as regulating authorities and policymakers.
  • Industry associations.

The study is useful in providing answers to several critical questions that are important for industry stakeholders, such as manufacturers, distributors, dealers and policymakers, about which market segments should be targeted over retail cosmetics outlets in coming years to strategize investments and capitalize on growth of the market.

Report Scope:


In this report, Pharmaceutical Contract Development and Manufacturing market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

In terms of type, the Global Pharmaceutical Contract Development and Manufacturing market is segregated into:


The report includes in-detail references of all the notable product categories as well as application specifications. The product segment is described on the basis of key player development traits, sales overview, volume based returns and the like.

  • Pharmaceutical Manufacturing Services
  • Biologics Manufacturing Services
  • Drug Development Services

By end-user also classify into, the Global Pharmaceutical Contract Development and Manufacturing market:


Global Pharmaceutical Contract Development and Manufacturing market also specifically underpins end-use application scope and their improvements based on technological developments and consumer preferences.

  • Big Pharma
  • Small Pharma
  • Generic Pharma
  • CRO

Highlights of this 2021-2027 Pharmaceutical Contract Development and Manufacturing Market Report:

  • Market dynamics, Pharmaceutical Contract Development and Manufacturing economy manufacturing, opportunities on the total pricing of this top manufacturer and improvement trend analysis;
  • Pharmaceutical Contract Development and Manufacturing industry players at the general regional industry and economy synopsis;
  • Deep analysis of the most significant market players included by Worldwide Pharmaceutical Contract Development and Manufacturing Market study report;
  • Understand more about the market plans that are increasingly now being adopted by leading Pharmaceutical Contract Development and Manufacturing businesses;
  • Evaluation of this market character, namely market development drivers, essential challengers, inhibitors, and chances;
  • Strategically profile the key players and comprehensively analyze their growth strategies.

Competitive Landscape:

Company Profiles: Detailed analysis of the major companies presents in the Pharmaceutical Contract Development and Manufacturing market.

Product Benchmarking: Benchmarking of most selling variant of all leading companies based on product type. In-depth analysis of benchmarking and recommendation on ideal product specifications.

Voice of Customer: Customer analysis by considering the major factors influencing the purchasing decision.

Available Customizations:

With the given market data, Data Lab Forecast offers customizations according to the companys specific needs. The following customization options are available for the report:

Channel Partner Analysis: Detailed list of distributors and dealers across the country.

Company Information: Detailed analysis and profiling of additional market players (up to five).

Product Information: Detailed analysis of new products in the market and their driving forces in the market.

In case you dont find what you are looking for, please get in touch with our custom research team at sales@datalabforecast.com

TableofContents 1ReportOverview
1.1StudyScope
1.2KeyMarketSegments
1.3PlayersCovered:RankingbyPharmaceuticalContractDevelopmentandManufacturingRevenue
1.4MarketAnalysisbyType
1.4.1GlobalPharmaceuticalContractDevelopmentandManufacturingMarketSizeGrowthRatebyType:2021VS2027
1.4.2PharmaceuticalManufacturingServices
1.4.3BiologicsManufacturingServices
1.4.4DrugDevelopmentServices
1.5MarketbyApplication
1.5.1GlobalPharmaceuticalContractDevelopmentandManufacturingMarketSharebyApplication:2021VS2027
1.5.2BigPharma
1.5.3SmallPharma
1.5.4GenericPharma
1.5.5CRO 1.6StudyObjectives 1.7YearsConsidered 2GlobalGrowthTrendsbyRegions
2.1PharmaceuticalContractDevelopmentandManufacturingMarketPerspective(2016-2027)
2.2PharmaceuticalContractDevelopmentandManufacturingGrowthTrendsbyRegions
2.2.1PharmaceuticalContractDevelopmentandManufacturingMarketSizebyRegions:2016VS2021VS2027
2.2.2PharmaceuticalContractDevelopmentandManufacturingHistoricMarketSharebyRegions(2016-2021)
2.2.3PharmaceuticalContractDevelopmentandManufacturingForecastedMarketSizebyRegions(2021-2027) 2.3IndustryTrendsandGrowthStrategy 2.3.1MarketTopTrends 2.3.2MarketDrivers
2.3.3MarketChallenges
2.3.4PortersFiveForcesAnalysis
2.3.5PharmaceuticalContractDevelopmentandManufacturingMarketGrowthStrategy
2.3.6PrimaryInterviewswithKeyPharmaceuticalContractDevelopmentandManufacturingPlayers(OpinionLeaders) 3CompetitionLandscapebyKeyPlayers
3.1GlobalTopPharmaceuticalContractDevelopmentandManufacturingPlayersbyMarketSize
3.1.1GlobalTopPharmaceuticalContractDevelopmentandManufacturingPlayersbyRevenue(2016-2021)
3.1.2GlobalPharmaceuticalContractDevelopmentandManufacturingRevenueMarketSharebyPlayers(2016-2021)
3.1.3GlobalPharmaceuticalContractDevelopmentandManufacturingMarketSharebyCompanyType(Tier1,Tier2andTier3)
3.2GlobalPharmaceuticalContractDevelopmentandManufacturingMarketConcentrationRatio
3.2.1GlobalPharmaceuticalContractDevelopmentandManufacturingMarketConcentrationRatio(CR5andHHI)
3.2.2GlobalTop10andTop5CompaniesbyPharmaceuticalContractDevelopmentandManufacturingRevenuein2020
3.3PharmaceuticalContractDevelopmentandManufacturingKeyPlayersHeadofficeandAreaServed
3.4KeyPlayersPharmaceuticalContractDevelopmentandManufacturingProductSolutionandService
3.5DateofEnterintoPharmaceuticalContractDevelopmentandManufacturingMarket
3.6Mergers&Acquisitions,ExpansionPlans 4BreakdownDatabyType(2016-2027)
4.1GlobalPharmaceuticalContractDevelopmentandManufacturingHistoricMarketSizebyType(2016-2021)
4.2GlobalPharmaceuticalContractDevelopmentandManufacturingForecastedMarketSizebyType(2021-2027) 5PharmaceuticalContractDevelopmentandManufacturingBreakdownDatabyApplication(2016-2027)
5.1GlobalPharmaceuticalContractDevelopmentandManufacturingMarketSizebyApplication(2016-2021)
5.2GlobalPharmaceuticalContractDevelopmentandManufacturingForecastedMarketSizebyApplication(2021-2027) 6NorthAmerica
6.1NorthAmericaPharmaceuticalContractDevelopmentandManufacturingMarketSize(2016-2021)
6.2PharmaceuticalContractDevelopmentandManufacturingKeyPlayersinNorthAmerica(2020-2021)
6.3NorthAmericaPharmaceuticalContractDevelopmentandManufacturingMarketSizebyType(2016-2021)
6.4NorthAmericaPharmaceuticalContractDevelopmentandManufacturingMarketSizebyApplication(2016-2021) 7Europe
7.1EuropePharmaceuticalContractDevelopmentandManufacturingMarketSize(2016-2021)
7.2PharmaceuticalContractDevelopmentandManufacturingKeyPlayersinEurope(2020-2021)
7.3EuropePharmaceuticalContractDevelopmentandManufacturingMarketSizebyType(2016-2021)
7.4EuropePharmaceuticalContractDevelopmentandManufacturingMarketSizebyApplication(2016-2021) 8China
8.1ChinaPharmaceuticalContractDevelopmentandManufacturingMarketSize(2016-2021)
8.2PharmaceuticalContractDevelopmentandManufacturingKeyPlayersinChina(2020-2021)
8.3ChinaPharmaceuticalContractDevelopmentandManufacturingMarketSizebyType(2016-2021)
8.4ChinaPharmaceuticalContractDevelopmentandManufacturingMarketSizebyApplication(2016-2021) 9Japan
9.1JapanPharmaceuticalContractDevelopmentandManufacturingMarketSize(2016-2021)
9.2PharmaceuticalContractDevelopmentandManufacturingKeyPlayersinJapan(2020-2021)
9.3JapanPharmaceuticalContractDevelopmentandManufacturingMarketSizebyType(2016-2021)
9.4JapanPharmaceuticalContractDevelopmentandManufacturingMarketSizebyApplication(2016-2021) 10SoutheastAsia
10.1SoutheastAsiaPharmaceuticalContractDevelopmentandManufacturingMarketSize(2016-2021)
10.2PharmaceuticalContractDevelopmentandManufacturingKeyPlayersinSoutheastAsia(2020-2021)
10.3SoutheastAsiaPharmaceuticalContractDevelopmentandManufacturingMarketSizebyType(2016-2021)
10.4SoutheastAsiaPharmaceuticalContractDevelopmentandManufacturingMarketSizebyApplication(2016-2021) 11India
11.1IndiaPharmaceuticalContractDevelopmentandManufacturingMarketSize(2016-2021)
11.2PharmaceuticalContractDevelopmentandManufacturingKeyPlayersinIndia(2020-2021)
11.3IndiaPharmaceuticalContractDevelopmentandManufacturingMarketSizebyType(2016-2021)
11.4IndiaPharmaceuticalContractDevelopmentandManufacturingMarketSizebyApplication(2016-2021) 12CentralandSouthAmerica
12.1CentralandSouthAmericaPharmaceuticalContractDevelopmentandManufacturingMarketSize(2016-2021)
12.2PharmaceuticalContractDevelopmentandManufacturingKeyPlayersinCentralandSouthAmerica(2020-2021)
12.3CentralandSouthAmericaPharmaceuticalContractDevelopmentandManufacturingMarketSizebyType(2016-2021)
12.4CentralandSouthAmericaPharmaceuticalContractDevelopmentandManufacturingMarketSizebyApplication(2016-2021) 13KeyPlayersProfiles
13.1ThermoFisherScientificInc.
13.1.1ThermoFisherScientificInc.CompanyDetails
13.1.2ThermoFisherScientificInc.BusinessOverviewandItsTotalRevenue
13.1.3ThermoFisherScientificInc.PharmaceuticalContractDevelopmentandManufacturingIntroduction
13.1.4ThermoFisherScientificInc.RevenueinPharmaceuticalContractDevelopmentandManufacturingBusiness(2016-2021))
13.1.5ThermoFisherScientificInc.RecentDevelopment
13.2Catalent,Inc.
13.2.1Catalent,Inc.CompanyDetails
13.2.2Catalent,Inc.BusinessOverviewandItsTotalRevenue
13.2.3Catalent,Inc.PharmaceuticalContractDevelopmentandManufacturingIntroduction
13.2.4Catalent,Inc.RevenueinPharmaceuticalContractDevelopmentandManufacturingBusiness(2016-2021)
13.2.5Catalent,Inc.RecentDevelopment
13.3LonzaGroupLtd
13.3.1LonzaGroupLtdCompanyDetails
13.3.2LonzaGroupLtdBusinessOverviewandItsTotalRevenue
13.3.3LonzaGroupLtdPharmaceuticalContractDevelopmentandManufacturingIntroduction
13.3.4LonzaGroupLtdRevenueinPharmaceuticalContractDevelopmentandManufacturingBusiness(2016-2021)
13.3.5LonzaGroupLtdRecentDevelopment
13.4RecipharmAB
13.4.1RecipharmABCompanyDetails
13.4.2RecipharmABBusinessOverviewandItsTotalRevenue
13.4.3RecipharmABPharmaceuticalContractDevelopmentandManufacturingIntroduction
13.4.4RecipharmABRevenueinPharmaceuticalContractDevelopmentandManufacturingBusiness(2016-2021)
13.4.5RecipharmABRecentDevelopment
13.5VetterPharmaInternationalGMBH
13.5.1VetterPharmaInternationalGMBHCompanyDetails
13.5.2VetterPharmaInternationalGMBHBusinessOverviewandItsTotalRevenue
13.5.3VetterPharmaInternationalGMBHPharmaceuticalContractDevelopmentandManufacturingIntroduction
13.5.4VetterPharmaInternationalGMBHRevenueinPharmaceuticalContractDevelopmentandManufacturingBusiness(2016-2021)
13.5.5VetterPharmaInternationalGMBHRecentDevelopment
13.6FAMARHealthCareServices
13.6.1FAMARHealthCareServicesCompanyDetails
13.6.2FAMARHealthCareServicesBusinessOverviewandItsTotalRevenue
13.6.3FAMARHealthCareServicesPharmaceuticalContractDevelopmentandManufacturingIntroduction
13.6.4FAMARHealthCareServicesRevenueinPharmaceuticalContractDevelopmentandManufacturingBusiness(2016-2021)
13.6.5FAMARHealthCareServicesRecentDevelopment
13.7AbbVieInc.
13.7.1AbbVieInc.CompanyDetails
13.7.2AbbVieInc.BusinessOverviewandItsTotalRevenue
13.7.3AbbVieInc.PharmaceuticalContractDevelopmentandManufacturingIntroduction
13.7.4AbbVieInc.RevenueinPharmaceuticalContractDevelopmentandManufacturingBusiness(2016-2021)
13.7.5AbbVieInc.RecentDevelopment
13.8AenovaGroup
13.8.1AenovaGroupCompanyDetails
13.8.2AenovaGroupBusinessOverviewandItsTotalRevenue
13.8.3AenovaGroupPharmaceuticalContractDevelopmentandManufacturingIntroduction
13.8.4AenovaGroupRevenueinPharmaceuticalContractDevelopmentandManufacturingBusiness(2016-2021)
13.8.5AenovaGroupRecentDevelopment
13.9ConsortMedicalplc
13.9.1ConsortMedicalplcCompanyDetails
13.9.2ConsortMedicalplcBusinessOverviewandItsTotalRevenue
13.9.3ConsortMedicalplcPharmaceuticalContractDevelopmentandManufacturingIntroduction
13.9.4ConsortMedicalplcRevenueinPharmaceuticalContractDevelopmentandManufacturingBusiness(2016-2021)
13.9.5ConsortMedicalplcRecentDevelopment
13.10AlmacGroup
13.10.1AlmacGroupCompanyDetails
13.10.2AlmacGroupBusinessOverviewandItsTotalRevenue
13.10.3AlmacGroupPharmaceuticalContractDevelopmentandManufacturingIntroduction
13.10.4AlmacGroupRevenueinPharmaceuticalContractDevelopmentandManufacturingBusiness(2016-2021)
13.10.5AlmacGroupRecentDevelopment
13.11SiegfriedHoldingAG
10.11.1SiegfriedHoldingAGCompanyDetails
10.11.2SiegfriedHoldingAGBusinessOverviewandItsTotalRevenue
10.11.3SiegfriedHoldingAGPharmaceuticalContractDevelopmentandManufacturingIntroduction
10.11.4SiegfriedHoldingAGRevenueinPharmaceuticalContractDevelopmentandManufacturingBusiness(2016-2021)
10.11.5SiegfriedHoldingAGRecentDevelopment
13.12BoehringerIngelheimInternationalGmbH
10.12.1BoehringerIngelheimInternationalGmbHCompanyDetails
10.12.2BoehringerIngelheimInternationalGmbHBusinessOverviewandItsTotalRevenue
10.12.3BoehringerIngelheimInternationalGmbHPharmaceuticalContractDevelopmentandManufacturingIntroduction
10.12.4BoehringerIngelheimInternationalGmbHRevenueinPharmaceuticalContractDevelopmentandManufacturingBusiness(2016-2021)
10.12.5BoehringerIngelheimInternationalGmbHRecentDevelopment
13.13EvonikIndustriesAG
10.13.1EvonikIndustriesAGCompanyDetails
10.13.2EvonikIndustriesAGBusinessOverviewandItsTotalRevenue
10.13.3EvonikIndustriesAGPharmaceuticalContractDevelopmentandManufacturingIntroduction
10.13.4EvonikIndustriesAGRevenueinPharmaceuticalContractDevelopmentandManufacturingBusiness(2016-2021)
10.13.5EvonikIndustriesAGRecentDevelopment 14Analyst'sViewpoints/Conclusions 15Appendix
15.1ResearchMethodology
15.1.1Methodology/ResearchApproach
15.1.2DataSource
15.2Disclaimer
15.3AuthorDetails

List of Tables
Table 1. Pharmaceutical Contract Development and Manufacturing Key Market Segments
Table 2. Key Players Covered: Ranking by Pharmaceutical Contract Development and Manufacturing Revenue
Table 3. Ranking of Global Top Pharmaceutical Contract Development and Manufacturing Manufacturers by Revenue (US$ Million) in 2020
Table 4. Global Pharmaceutical Contract Development and Manufacturing Market Size Growth Rate by Type (US$ Million): 2021 VS 2027
Table 5. Key Players of Pharmaceutical Manufacturing Services
Table 6. Key Players of Biologics Manufacturing Services
Table 7. Key Players of Drug Development Services
Table 8. Global Pharmaceutical Contract Development and Manufacturing Market Size Growth by Application (US$ Million): 2021 VS 2027
Table 9. Global Pharmaceutical Contract Development and Manufacturing Market Size by Regions (US$ Million): 2021 VS 2027
Table 10. Global Pharmaceutical Contract Development and Manufacturing Market Size by Regions (2016-2021) (US$ Million)
Table 11. Global Pharmaceutical Contract Development and Manufacturing Market Share by Regions (2016-2021)
Table 12. Global Pharmaceutical Contract Development and Manufacturing Forecasted Market Size by Regions (2021-2027) (US$ Million)
Table 13. Global Pharmaceutical Contract Development and Manufacturing Market Share by Regions (2021-2027)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Pharmaceutical Contract Development and Manufacturing Market Growth Strategy
Table 18. Main Points Interviewed from Key Pharmaceutical Contract Development and Manufacturing Players
Table 19. Global Pharmaceutical Contract Development and Manufacturing Revenue by Players (2016-2021) (Million US$)
Table 20. Global Pharmaceutical Contract Development and Manufacturing Market Share by Players (2016-2021)
Table 21. Global Top Pharmaceutical Contract Development and Manufacturing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmaceutical Contract Development and Manufacturing as of 2020)
Table 22. Global Pharmaceutical Contract Development and Manufacturing by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Pharmaceutical Contract Development and Manufacturing Product Solution and Service
Table 25. Date of Enter into Pharmaceutical Contract Development and Manufacturing Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Pharmaceutical Contract Development and Manufacturing Market Size by Type (2016-2021) (Million US$)
Table 28. Global Pharmaceutical Contract Development and Manufacturing Market Size Share by Type (2016-2021)
Table 29. Global Pharmaceutical Contract Development and Manufacturing Revenue Market Share by Type (2021-2027)
Table 30. Global Pharmaceutical Contract Development and Manufacturing Market Size Share by Application (2016-2021)
Table 31. Global Pharmaceutical Contract Development and Manufacturing Market Size by Application (2016-2021) (Million US$)
Table 32. Global Pharmaceutical Contract Development and Manufacturing Market Size Share by Application (2021-2027)
Table 33. North America Key Players Pharmaceutical Contract Development and Manufacturing Revenue (2020-2021) (Million US$)
Table 34. North America Key Players Pharmaceutical Contract Development and Manufacturing Market Share (2020-2021)
Table 35. North America Pharmaceutical Contract Development and Manufacturing Market Size by Type (2016-2021) (Million US$)
Table 36. North America Pharmaceutical Contract Development and Manufacturing Market Share by Type (2016-2021)
Table 37. North America Pharmaceutical Contract Development and Manufacturing Market Size by Application (2016-2021) (Million US$)
Table 38. North America Pharmaceutical Contract Development and Manufacturing Market Share by Application (2016-2021)
Table 39. Europe Key Players Pharmaceutical Contract Development and Manufacturing Revenue (2020-2021) (Million US$)
Table 40. Europe Key Players Pharmaceutical Contract Development and Manufacturing Market Share (2020-2021)
Table 41. Europe Pharmaceutical Contract Development and Manufacturing Market Size by Type (2016-2021) (Million US$)
Table 42. Europe Pharmaceutical Contract Development and Manufacturing Market Share by Type (2016-2021)
Table 43. Europe Pharmaceutical Contract Development and Manufacturing Market Size by Application (2016-2021) (Million US$)
Table 44. Europe Pharmaceutical Contract Development and Manufacturing Market Share by Application (2016-2021)
Table 45. China Key Players Pharmaceutical Contract Development and Manufacturing Revenue (2020-2021) (Million US$)
Table 46. China Key Players Pharmaceutical Contract Development and Manufacturing Market Share (2020-2021)
Table 47. China Pharmaceutical Contract Development and Manufacturing Market Size by Type (2016-2021) (Million US$)
Table 48. China Pharmaceutical Contract Development and Manufacturing Market Share by Type (2016-2021)
Table 49. China Pharmaceutical Contract Development and Manufacturing Market Size by Application (2016-2021) (Million US$)
Table 50. China Pharmaceutical Contract Development and Manufacturing Market Share by Application (2016-2021)
Table 51. Japan Key Players Pharmaceutical Contract Development and Manufacturing Revenue (2020-2021) (Million US$)
Table 52. Japan Key Players Pharmaceutical Contract Development and Manufacturing Market Share (2020-2021)
Table 53. Japan Pharmaceutical Contract Development and Manufacturing Market Size by Type (2016-2021) (Million US$)
Table 54. Japan Pharmaceutical Contract Development and Manufacturing Market Share by Type (2016-2021)
Table 55. Japan Pharmaceutical Contract Development and Manufacturing Market Size by Application (2016-2021) (Million US$)
Table 56. Japan Pharmaceutical Contract Development and Manufacturing Market Share by Application (2016-2021)
Table 57. Southeast Asia Key Players Pharmaceutical Contract Development and Manufacturing Revenue (2020-2021) (Million US$)
Table 58. Southeast Asia Key Players Pharmaceutical Contract Development and Manufacturing Market Share (2020-2021)
Table 59. Southeast Asia Pharmaceutical Contract Development and Manufacturing Market Size by Type (2016-2021) (Million US$)
Table 60. Southeast Asia Pharmaceutical Contract Development and Manufacturing Market Share by Type (2016-2021)
Table 61. Southeast Asia Pharmaceutical Contract Development and Manufacturing Market Size by Application (2016-2021) (Million US$)
Table 62. Southeast Asia Pharmaceutical Contract Development and Manufacturing Market Share by Application (2016-2021)
Table 63. India Key Players Pharmaceutical Contract Development and Manufacturing Revenue (2020-2021) (Million US$)
Table 64. India Key Players Pharmaceutical Contract Development and Manufacturing Market Share (2020-2021)
Table 65. India Pharmaceutical Contract Development and Manufacturing Market Size by Type (2016-2021) (Million US$)
Table 66. India Pharmaceutical Contract Development and Manufacturing Market Share by Type (2016-2021)
Table 67. India Pharmaceutical Contract Development and Manufacturing Market Size by Application (2016-2021) (Million US$)
Table 68. India Pharmaceutical Contract Development and Manufacturing Market Share by Application (2016-2021)
Table 69. Central and South America Key Players Pharmaceutical Contract Development and Manufacturing Revenue (2020-2021) (Million US$)
Table 70. Central and South America Key Players Pharmaceutical Contract Development and Manufacturing Market Share (2020-2021)
Table 71. Central and South America Pharmaceutical Contract Development and Manufacturing Market Size by Type (2016-2021) (Million US$)
Table 72. Central and South America Pharmaceutical Contract Development and Manufacturing Market Share by Type (2016-2021)
Table 73. Central and South America Pharmaceutical Contract Development and Manufacturing Market Size by Application (2016-2021) (Million US$)
Table 74. Central and South America Pharmaceutical Contract Development and Manufacturing Market Share by Application (2016-2021)
Table 75. Thermo Fisher Scientific Inc. Company Details
Table 76. Thermo Fisher Scientific Inc. Business Overview
Table 77. Thermo Fisher Scientific Inc. Product
Table 78. Thermo Fisher Scientific Inc. Revenue in Pharmaceutical Contract Development and Manufacturing Business (2016-2021) (Million US$)
Table 79. Thermo Fisher Scientific Inc. Recent Development
Table 80. Catalent, Inc. Company Details
Table 81. Catalent, Inc. Business Overview
Table 82. Catalent, Inc. Product
Table 83. Catalent, Inc. Revenue in Pharmaceutical Contract Development and Manufacturing Business (2016-2021) (Million US$)
Table 84. Catalent, Inc. Recent Development
Table 85. Lonza Group Ltd Company Details
Table 86. Lonza Group Ltd Business Overview
Table 87. Lonza Group Ltd Product
Table 88. Lonza Group Ltd Revenue in Pharmaceutical Contract Development and Manufacturing Business (2016-2021) (Million US$)
Table 89. Lonza Group Ltd Recent Development
Table 90. Recipharm AB Company Details
Table 91. Recipharm AB Business Overview
Table 92. Recipharm AB Product
Table 93. Recipharm AB Revenue in Pharmaceutical Contract Development and Manufacturing Business (2016-2021) (Million US$)
Table 94. Recipharm AB Recent Development
Table 95. Vetter Pharma International GMBH Company Details
Table 96. Vetter Pharma International GMBH Business Overview
Table 97. Vetter Pharma International GMBH Product
Table 98. Vetter Pharma International GMBH Revenue in Pharmaceutical Contract Development and Manufacturing Business (2016-2021) (Million US$)
Table 99. Vetter Pharma International GMBH Recent Development
Table 100. FAMAR Health Care Services Company Details
Table 101. FAMAR Health Care Services Business Overview
Table 102. FAMAR Health Care Services Product
Table 103. FAMAR Health Care Services Revenue in Pharmaceutical Contract Development and Manufacturing Business (2016-2021) (Million US$)
Table 104. FAMAR Health Care Services Recent Development
Table 105. AbbVie Inc. Company Details
Table 106. AbbVie Inc. Business Overview
Table 107. AbbVie Inc. Product
Table 108. AbbVie Inc. Revenue in Pharmaceutical Contract Development and Manufacturing Business (2016-2021) (Million US$)
Table 109. AbbVie Inc. Recent Development
Table 110. Aenova Group Business Overview
Table 111. Aenova Group Product
Table 112. Aenova Group Company Details
Table 113. Aenova Group Revenue in Pharmaceutical Contract Development and Manufacturing Business (2016-2021) (Million US$)
Table 114. Aenova Group Recent Development
Table 115. Consort Medical plc Company Details
Table 116. Consort Medical plc Business Overview
Table 117. Consort Medical plc Product
Table 118. Consort Medical plc Revenue in Pharmaceutical Contract Development and Manufacturing Business (2016-2021) (Million US$)
Table 119. Consort Medical plc Recent Development
Table 120. Almac Group Company Details
Table 121. Almac Group Business Overview
Table 122. Almac Group Product
Table 123. Almac Group Revenue in Pharmaceutical Contract Development and Manufacturing Business (2016-2021) (Million US$)
Table 124. Almac Group Recent Development
Table 125. Siegfried Holding AG Company Details
Table 126. Siegfried Holding AG Business Overview
Table 127. Siegfried Holding AG Product
Table 128. Siegfried Holding AG Revenue in Pharmaceutical Contract Development and Manufacturing Business (2016-2021) (Million US$)
Table 129. Siegfried Holding AG Recent Development
Table 130. Boehringer Ingelheim International GmbH Company Details
Table 131. Boehringer Ingelheim International GmbH Business Overview
Table 132. Boehringer Ingelheim International GmbH Product
Table 133. Boehringer Ingelheim International GmbH Revenue in Pharmaceutical Contract Development and Manufacturing Business (2016-2021) (Million US$)
Table 134. Boehringer Ingelheim International GmbH Recent Development
Table 135. Evonik Industries AG Company Details
Table 136. Evonik Industries AG Business Overview
Table 137. Evonik Industries AG Product
Table 138. Evonik Industries AG Revenue in Pharmaceutical Contract Development and Manufacturing Business (2016-2021) (Million US$)
Table 139. Evonik Industries AG Recent Development
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pharmaceutical Contract Development and Manufacturing Market Share by Type: 2021 VS 2027
Figure 2. Pharmaceutical Manufacturing Services Features
Figure 3. Biologics Manufacturing Services Features
Figure 4. Drug Development Services Features
Figure 5. Global Pharmaceutical Contract Development and Manufacturing Market Share by Application: 2021 VS 2027
Figure 6. Big Pharma Case Studies
Figure 7. Small Pharma Case Studies
Figure 8. Generic Pharma Case Studies
Figure 9. CRO Case Studies
Figure 10. Pharmaceutical Contract Development and Manufacturing Report Years Considered
Figure 11. Global Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth 2016-2027 (US$ Million)
Figure 12. Global Pharmaceutical Contract Development and Manufacturing Market Share by Regions: 2021 VS 2027
Figure 13. Global Pharmaceutical Contract Development and Manufacturing Market Share by Regions (2021-2027)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Pharmaceutical Contract Development and Manufacturing Market Share by Players in 2020
Figure 16. Global Top Pharmaceutical Contract Development and Manufacturing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmaceutical Contract Development and Manufacturing as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Pharmaceutical Contract Development and Manufacturing Revenue in 2020
Figure 18. North America Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2016-2021) (Million US$)
Figure 19. Europe Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2016-2021) (Million US$)
Figure 20. China Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2016-2021) (Million US$)
Figure 21. Japan Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2016-2021) (Million US$)
Figure 22. Southeast Asia Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2016-2021) (Million US$)
Figure 23. India Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2016-2021) (Million US$)
Figure 24. Central and South America Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2016-2021) (Million US$)
Figure 25. Thermo Fisher Scientific Inc. Total Revenue (US$ Million): 2020 Compared with 2018
Figure 26. Thermo Fisher Scientific Inc. Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2016-2021)
Figure 27. Catalent, Inc. Total Revenue (US$ Million): 2020 Compared with 2018
Figure 28. Catalent, Inc. Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2016-2021)
Figure 29. Lonza Group Ltd Total Revenue (US$ Million): 2020 Compared with 2018
Figure 30. Lonza Group Ltd Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2016-2021)
Figure 31. Recipharm AB Total Revenue (US$ Million): 2020 Compared with 2018
Figure 32. Recipharm AB Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2016-2021)
Figure 33. Vetter Pharma International GMBH Total Revenue (US$ Million): 2020 Compared with 2018
Figure 34. Vetter Pharma International GMBH Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2016-2021)
Figure 35. FAMAR Health Care Services Total Revenue (US$ Million): 2020 Compared with 2018
Figure 36. FAMAR Health Care Services Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2016-2021)
Figure 37. AbbVie Inc. Total Revenue (US$ Million): 2020 Compared with 2018
Figure 38. AbbVie Inc. Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2016-2021)
Figure 39. Aenova Group Total Revenue (US$ Million): 2020 Compared with 2018
Figure 40. Aenova Group Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2016-2021)
Figure 41. Consort Medical plc Total Revenue (US$ Million): 2020 Compared with 2018
Figure 42. Consort Medical plc Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2016-2021)
Figure 43. Almac Group Total Revenue (US$ Million): 2020 Compared with 2018
Figure 44. Almac Group Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2016-2021)
Figure 45. Siegfried Holding AG Total Revenue (US$ Million): 2020 Compared with 2018
Figure 46. Siegfried Holding AG Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2016-2021)
Figure 47. Boehringer Ingelheim International GmbH Total Revenue (US$ Million): 2020 Compared with 2018
Figure 48. Boehringer Ingelheim International GmbH Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2016-2021)
Figure 49. Evonik Industries AG Total Revenue (US$ Million): 2020 Compared with 2018
Figure 50. Evonik Industries AG Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2016-2021)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed

Pharmaceutical Contract Development and Manufacturing Market Segments


Pharmaceutical Contract Development and Manufacturing Product Type Outlook (Revenue, USD Million, 2021 2027)


  • Pharmaceutical Manufacturing Services
  • Biologics Manufacturing Services
  • Drug Development Services

Pharmaceutical Contract Development and Manufacturing Application Outlook (Revenue, USD Million, 2021 2027)


  • Big Pharma
  • Small Pharma
  • Generic Pharma
  • CRO

Pharmaceutical Contract Development and Manufacturing Regional Outlook (Revenue, USD Million, 2021 2027)


  • North America
    • Pharmaceutical Contract Development and Manufacturing market, By Product Type Outlook
      • Pharmaceutical Manufacturing Services
      • Biologics Manufacturing Services
      • Drug Development Services

    • Pharmaceutical Contract Development and Manufacturing market, By Application Outlook
      • Big Pharma
      • Small Pharma
      • Generic Pharma
      • CRO

  • Europe
    • Pharmaceutical Contract Development and Manufacturing market, By Product Type Outlook
      • Pharmaceutical Manufacturing Services
      • Biologics Manufacturing Services
      • Drug Development Services

    • Pharmaceutical Contract Development and Manufacturing market, By Application Outlook
      • Big Pharma
      • Small Pharma
      • Generic Pharma
      • CRO

  • Asia Pacific
    • Pharmaceutical Contract Development and Manufacturing market, By Product Type Outlook
      • Pharmaceutical Manufacturing Services
      • Biologics Manufacturing Services
      • Drug Development Services

    • Pharmaceutical Contract Development and Manufacturing market, By Application Outlook
      • Big Pharma
      • Small Pharma
      • Generic Pharma
      • CRO

  • Latin America
    • Pharmaceutical Contract Development and Manufacturing market, By Product Type Outlook
      • Pharmaceutical Manufacturing Services
      • Biologics Manufacturing Services
      • Drug Development Services

    • Pharmaceutical Contract Development and Manufacturing market, By Application Outlook
      • Big Pharma
      • Small Pharma
      • Generic Pharma
      • CRO

  • Middle East & Africa
    • Pharmaceutical Contract Development and Manufacturing market, By Product Type Outlook
      • Pharmaceutical Manufacturing Services
      • Biologics Manufacturing Services
      • Drug Development Services

    • Pharmaceutical Contract Development and Manufacturing market, By Application Outlook
      • Big Pharma
      • Small Pharma
      • Generic Pharma
      • CRO

Report Content:


Qualitative Analysis


  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porters analysis
  • PESTEL Analysis
  • Value Chain Analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Overview
    • Financials
    • Product benchmarking
    • Latest strategic developments

Quantitative Analysis


  • Market size, estimates, and forecasts from 2021 - 2027
  • Market revenue estimates for product type up to 2027
  • Market revenue estimates for application type up to 2027
  • Regional market size and forecast up to 2027
  • Company financials

Report Description


The Global Pharmaceutical Contract Development and Manufacturing Market Report provides Insightful information to the clients enhancing their basic leadership capacity identified with the global Pharmaceutical Contract Development and Manufacturing Market business, including market dynamics, segmentation, competition, and regional growth. The strategy of expansion has been adopted by key players who are increasing their production capacities to cater to the increasing demand for various application.

New traders at intervals the Pharmaceutical Contract Development and Manufacturing Market face strong competition from ancient world traders as they try with technological revolutions, dependableness and commonplace of Pharmaceutical Contract Development and Manufacturing Market product affairs. The report is at risk of project regarding this Pharmaceutical Contract Development and Manufacturing Market evolutions and additionally the magnitude of competition, value and extra.

Leading market players: (Option 1: Free 25% Customization Profiles of 5 Additional Companies of your Choice)


This business intelligence report offers profiling of reputed companies that are operating in the market. Companies such as:

  • Thermo Fisher Scientific Inc.
  • Catalent, Inc.
  • Lonza Group Ltd
  • Recipharm AB
  • Vetter Pharma International GMBH
  • FAMAR Health Care Services
  • AbbVie Inc.
  • Aenova Group
  • Consort Medical plc
  • Almac Group
  • Siegfried Holding AG
  • Boehringer Ingelheim International GmbH
  • Evonik Industries AG

Others players have been profiled into detail so as to offer a glimpse of the market leaders. Moreover, parameters such as Pharmaceutical Contract Development and Manufacturing related investment & spending and developments by major players of the market are tracked in this Global report.

Years considered for the study:


Pharmaceutical Contract Development and Manufacturing Market

Pharmaceutical Contract Development and Manufacturing Market

Report Highlights:


The Pharmaceutical Contract Development and Manufacturing Market is widely partitioned reliant on the predictable updates in the enhancement of parameters for example, quality, trustworthiness, end customer solicitations, applications, and others. The Pharmaceutical Contract Development and Manufacturing Market report contains general successful parameters, confinements, and besides has in detail illumination of the noteworthy data close by the present and future examples that may concern the advancement. The comprehensive Pharmaceutical Contract Development and Manufacturing Market report elucidates within and outside representation of current advancements, parameters, and establishments.

The key regions analyzed in this study include North America, Europe, Japan, China, India, Korea, South East Asia, South America, Middle East and African countries. The leading players of Pharmaceutical Contract Development and Manufacturing Market and their geographical presence across the globe are estimated based on production capacity, utilization ratio, consumer base, demand and supply scenario, profit margin and Pharmaceutical Contract Development and Manufacturing marketers.

Data Lab Forecast performed primary as well as exhaustive secondary research for this study. We conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, DLF was able to include manufacturers that could not be identified due to the limitations of secondary research. We analysed product offerings, distribution channel and regional presence of all major companies in the industry.

Data Lab Forecast calculated the market size for the Pharmaceutical Contract Development and Manufacturing market using a bottom-up approach, wherein manufacturers value data for different type (Pharmaceutical Manufacturing Services, Biologics Manufacturing Services, Drug Development Services), of Pharmaceutical Contract Development and Manufacturing market was recorded as well as forecast for the future years was made. Data Lab Forecast sourced these values from industry experts and company representatives, and externally validated through analyzing historical sales data of respective manufacturers to arrive at the overall market size. Various secondary sources such as company annual reports, white papers, investor presentations and financial reports were also studied by Data Lab Forecast.

Pharmaceutical Contract Development and Manufacturing Market

Pharmaceutical Contract Development and Manufacturing Market

Key Target Audience:


  • Pharmaceutical Contract Development and Manufacturing market companies.
  • Research organizations and consulting companies.
  • Organizations, associations and alliances related to the Pharmaceutical Contract Development and Manufacturing market industry.
  • Government bodies such as regulating authorities and policymakers.
  • Industry associations.

The study is useful in providing answers to several critical questions that are important for industry stakeholders, such as manufacturers, distributors, dealers and policymakers, about which market segments should be targeted over retail cosmetics outlets in coming years to strategize investments and capitalize on growth of the market.

Report Scope:


In this report, Pharmaceutical Contract Development and Manufacturing market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

In terms of type, the Global Pharmaceutical Contract Development and Manufacturing market is segregated into:


The report includes in-detail references of all the notable product categories as well as application specifications. The product segment is described on the basis of key player development traits, sales overview, volume based returns and the like.

  • Pharmaceutical Manufacturing Services
  • Biologics Manufacturing Services
  • Drug Development Services

By end-user also classify into, the Global Pharmaceutical Contract Development and Manufacturing market:


Global Pharmaceutical Contract Development and Manufacturing market also specifically underpins end-use application scope and their improvements based on technological developments and consumer preferences.

  • Big Pharma
  • Small Pharma
  • Generic Pharma
  • CRO

Highlights of this 2021-2027 Pharmaceutical Contract Development and Manufacturing Market Report:

  • Market dynamics, Pharmaceutical Contract Development and Manufacturing economy manufacturing, opportunities on the total pricing of this top manufacturer and improvement trend analysis;
  • Pharmaceutical Contract Development and Manufacturing industry players at the general regional industry and economy synopsis;
  • Deep analysis of the most significant market players included by Worldwide Pharmaceutical Contract Development and Manufacturing Market study report;
  • Understand more about the market plans that are increasingly now being adopted by leading Pharmaceutical Contract Development and Manufacturing businesses;
  • Evaluation of this market character, namely market development drivers, essential challengers, inhibitors, and chances;
  • Strategically profile the key players and comprehensively analyze their growth strategies.

Competitive Landscape:

Company Profiles: Detailed analysis of the major companies presents in the Pharmaceutical Contract Development and Manufacturing market.

Product Benchmarking: Benchmarking of most selling variant of all leading companies based on product type. In-depth analysis of benchmarking and recommendation on ideal product specifications.

Voice of Customer: Customer analysis by considering the major factors influencing the purchasing decision.

Available Customizations:

With the given market data, Data Lab Forecast offers customizations according to the companys specific needs. The following customization options are available for the report:

Channel Partner Analysis: Detailed list of distributors and dealers across the country.

Company Information: Detailed analysis and profiling of additional market players (up to five).

Product Information: Detailed analysis of new products in the market and their driving forces in the market.

In case you dont find what you are looking for, please get in touch with our custom research team at sales@datalabforecast.com
TableofContents 1ReportOverview
1.1StudyScope
1.2KeyMarketSegments
1.3PlayersCovered:RankingbyPharmaceuticalContractDevelopmentandManufacturingRevenue
1.4MarketAnalysisbyType
1.4.1GlobalPharmaceuticalContractDevelopmentandManufacturingMarketSizeGrowthRatebyType:2021VS2027
1.4.2PharmaceuticalManufacturingServices
1.4.3BiologicsManufacturingServices
1.4.4DrugDevelopmentServices
1.5MarketbyApplication
1.5.1GlobalPharmaceuticalContractDevelopmentandManufacturingMarketSharebyApplication:2021VS2027
1.5.2BigPharma
1.5.3SmallPharma
1.5.4GenericPharma
1.5.5CRO 1.6StudyObjectives 1.7YearsConsidered 2GlobalGrowthTrendsbyRegions
2.1PharmaceuticalContractDevelopmentandManufacturingMarketPerspective(2016-2027)
2.2PharmaceuticalContractDevelopmentandManufacturingGrowthTrendsbyRegions
2.2.1PharmaceuticalContractDevelopmentandManufacturingMarketSizebyRegions:2016VS2021VS2027
2.2.2PharmaceuticalContractDevelopmentandManufacturingHistoricMarketSharebyRegions(2016-2021)
2.2.3PharmaceuticalContractDevelopmentandManufacturingForecastedMarketSizebyRegions(2021-2027) 2.3IndustryTrendsandGrowthStrategy 2.3.1MarketTopTrends 2.3.2MarketDrivers
2.3.3MarketChallenges
2.3.4PortersFiveForcesAnalysis
2.3.5PharmaceuticalContractDevelopmentandManufacturingMarketGrowthStrategy
2.3.6PrimaryInterviewswithKeyPharmaceuticalContractDevelopmentandManufacturingPlayers(OpinionLeaders) 3CompetitionLandscapebyKeyPlayers
3.1GlobalTopPharmaceuticalContractDevelopmentandManufacturingPlayersbyMarketSize
3.1.1GlobalTopPharmaceuticalContractDevelopmentandManufacturingPlayersbyRevenue(2016-2021)
3.1.2GlobalPharmaceuticalContractDevelopmentandManufacturingRevenueMarketSharebyPlayers(2016-2021)
3.1.3GlobalPharmaceuticalContractDevelopmentandManufacturingMarketSharebyCompanyType(Tier1,Tier2andTier3)
3.2GlobalPharmaceuticalContractDevelopmentandManufacturingMarketConcentrationRatio
3.2.1GlobalPharmaceuticalContractDevelopmentandManufacturingMarketConcentrationRatio(CR5andHHI)
3.2.2GlobalTop10andTop5CompaniesbyPharmaceuticalContractDevelopmentandManufacturingRevenuein2020
3.3PharmaceuticalContractDevelopmentandManufacturingKeyPlayersHeadofficeandAreaServed
3.4KeyPlayersPharmaceuticalContractDevelopmentandManufacturingProductSolutionandService
3.5DateofEnterintoPharmaceuticalContractDevelopmentandManufacturingMarket
3.6Mergers&Acquisitions,ExpansionPlans 4BreakdownDatabyType(2016-2027)
4.1GlobalPharmaceuticalContractDevelopmentandManufacturingHistoricMarketSizebyType(2016-2021)
4.2GlobalPharmaceuticalContractDevelopmentandManufacturingForecastedMarketSizebyType(2021-2027) 5PharmaceuticalContractDevelopmentandManufacturingBreakdownDatabyApplication(2016-2027)
5.1GlobalPharmaceuticalContractDevelopmentandManufacturingMarketSizebyApplication(2016-2021)
5.2GlobalPharmaceuticalContractDevelopmentandManufacturingForecastedMarketSizebyApplication(2021-2027) 6NorthAmerica
6.1NorthAmericaPharmaceuticalContractDevelopmentandManufacturingMarketSize(2016-2021)
6.2PharmaceuticalContractDevelopmentandManufacturingKeyPlayersinNorthAmerica(2020-2021)
6.3NorthAmericaPharmaceuticalContractDevelopmentandManufacturingMarketSizebyType(2016-2021)
6.4NorthAmericaPharmaceuticalContractDevelopmentandManufacturingMarketSizebyApplication(2016-2021) 7Europe
7.1EuropePharmaceuticalContractDevelopmentandManufacturingMarketSize(2016-2021)
7.2PharmaceuticalContractDevelopmentandManufacturingKeyPlayersinEurope(2020-2021)
7.3EuropePharmaceuticalContractDevelopmentandManufacturingMarketSizebyType(2016-2021)
7.4EuropePharmaceuticalContractDevelopmentandManufacturingMarketSizebyApplication(2016-2021) 8China
8.1ChinaPharmaceuticalContractDevelopmentandManufacturingMarketSize(2016-2021)
8.2PharmaceuticalContractDevelopmentandManufacturingKeyPlayersinChina(2020-2021)
8.3ChinaPharmaceuticalContractDevelopmentandManufacturingMarketSizebyType(2016-2021)
8.4ChinaPharmaceuticalContractDevelopmentandManufacturingMarketSizebyApplication(2016-2021) 9Japan
9.1JapanPharmaceuticalContractDevelopmentandManufacturingMarketSize(2016-2021)
9.2PharmaceuticalContractDevelopmentandManufacturingKeyPlayersinJapan(2020-2021)
9.3JapanPharmaceuticalContractDevelopmentandManufacturingMarketSizebyType(2016-2021)
9.4JapanPharmaceuticalContractDevelopmentandManufacturingMarketSizebyApplication(2016-2021) 10SoutheastAsia
10.1SoutheastAsiaPharmaceuticalContractDevelopmentandManufacturingMarketSize(2016-2021)
10.2PharmaceuticalContractDevelopmentandManufacturingKeyPlayersinSoutheastAsia(2020-2021)
10.3SoutheastAsiaPharmaceuticalContractDevelopmentandManufacturingMarketSizebyType(2016-2021)
10.4SoutheastAsiaPharmaceuticalContractDevelopmentandManufacturingMarketSizebyApplication(2016-2021) 11India
11.1IndiaPharmaceuticalContractDevelopmentandManufacturingMarketSize(2016-2021)
11.2PharmaceuticalContractDevelopmentandManufacturingKeyPlayersinIndia(2020-2021)
11.3IndiaPharmaceuticalContractDevelopmentandManufacturingMarketSizebyType(2016-2021)
11.4IndiaPharmaceuticalContractDevelopmentandManufacturingMarketSizebyApplication(2016-2021) 12CentralandSouthAmerica
12.1CentralandSouthAmericaPharmaceuticalContractDevelopmentandManufacturingMarketSize(2016-2021)
12.2PharmaceuticalContractDevelopmentandManufacturingKeyPlayersinCentralandSouthAmerica(2020-2021)
12.3CentralandSouthAmericaPharmaceuticalContractDevelopmentandManufacturingMarketSizebyType(2016-2021)
12.4CentralandSouthAmericaPharmaceuticalContractDevelopmentandManufacturingMarketSizebyApplication(2016-2021) 13KeyPlayersProfiles
13.1ThermoFisherScientificInc.
13.1.1ThermoFisherScientificInc.CompanyDetails
13.1.2ThermoFisherScientificInc.BusinessOverviewandItsTotalRevenue
13.1.3ThermoFisherScientificInc.PharmaceuticalContractDevelopmentandManufacturingIntroduction
13.1.4ThermoFisherScientificInc.RevenueinPharmaceuticalContractDevelopmentandManufacturingBusiness(2016-2021))
13.1.5ThermoFisherScientificInc.RecentDevelopment
13.2Catalent,Inc.
13.2.1Catalent,Inc.CompanyDetails
13.2.2Catalent,Inc.BusinessOverviewandItsTotalRevenue
13.2.3Catalent,Inc.PharmaceuticalContractDevelopmentandManufacturingIntroduction
13.2.4Catalent,Inc.RevenueinPharmaceuticalContractDevelopmentandManufacturingBusiness(2016-2021)
13.2.5Catalent,Inc.RecentDevelopment
13.3LonzaGroupLtd
13.3.1LonzaGroupLtdCompanyDetails
13.3.2LonzaGroupLtdBusinessOverviewandItsTotalRevenue
13.3.3LonzaGroupLtdPharmaceuticalContractDevelopmentandManufacturingIntroduction
13.3.4LonzaGroupLtdRevenueinPharmaceuticalContractDevelopmentandManufacturingBusiness(2016-2021)
13.3.5LonzaGroupLtdRecentDevelopment
13.4RecipharmAB
13.4.1RecipharmABCompanyDetails
13.4.2RecipharmABBusinessOverviewandItsTotalRevenue
13.4.3RecipharmABPharmaceuticalContractDevelopmentandManufacturingIntroduction
13.4.4RecipharmABRevenueinPharmaceuticalContractDevelopmentandManufacturingBusiness(2016-2021)
13.4.5RecipharmABRecentDevelopment
13.5VetterPharmaInternationalGMBH
13.5.1VetterPharmaInternationalGMBHCompanyDetails
13.5.2VetterPharmaInternationalGMBHBusinessOverviewandItsTotalRevenue
13.5.3VetterPharmaInternationalGMBHPharmaceuticalContractDevelopmentandManufacturingIntroduction
13.5.4VetterPharmaInternationalGMBHRevenueinPharmaceuticalContractDevelopmentandManufacturingBusiness(2016-2021)
13.5.5VetterPharmaInternationalGMBHRecentDevelopment
13.6FAMARHealthCareServices
13.6.1FAMARHealthCareServicesCompanyDetails
13.6.2FAMARHealthCareServicesBusinessOverviewandItsTotalRevenue
13.6.3FAMARHealthCareServicesPharmaceuticalContractDevelopmentandManufacturingIntroduction
13.6.4FAMARHealthCareServicesRevenueinPharmaceuticalContractDevelopmentandManufacturingBusiness(2016-2021)
13.6.5FAMARHealthCareServicesRecentDevelopment
13.7AbbVieInc.
13.7.1AbbVieInc.CompanyDetails
13.7.2AbbVieInc.BusinessOverviewandItsTotalRevenue
13.7.3AbbVieInc.PharmaceuticalContractDevelopmentandManufacturingIntroduction
13.7.4AbbVieInc.RevenueinPharmaceuticalContractDevelopmentandManufacturingBusiness(2016-2021)
13.7.5AbbVieInc.RecentDevelopment
13.8AenovaGroup
13.8.1AenovaGroupCompanyDetails
13.8.2AenovaGroupBusinessOverviewandItsTotalRevenue
13.8.3AenovaGroupPharmaceuticalContractDevelopmentandManufacturingIntroduction
13.8.4AenovaGroupRevenueinPharmaceuticalContractDevelopmentandManufacturingBusiness(2016-2021)
13.8.5AenovaGroupRecentDevelopment
13.9ConsortMedicalplc
13.9.1ConsortMedicalplcCompanyDetails
13.9.2ConsortMedicalplcBusinessOverviewandItsTotalRevenue
13.9.3ConsortMedicalplcPharmaceuticalContractDevelopmentandManufacturingIntroduction
13.9.4ConsortMedicalplcRevenueinPharmaceuticalContractDevelopmentandManufacturingBusiness(2016-2021)
13.9.5ConsortMedicalplcRecentDevelopment
13.10AlmacGroup
13.10.1AlmacGroupCompanyDetails
13.10.2AlmacGroupBusinessOverviewandItsTotalRevenue
13.10.3AlmacGroupPharmaceuticalContractDevelopmentandManufacturingIntroduction
13.10.4AlmacGroupRevenueinPharmaceuticalContractDevelopmentandManufacturingBusiness(2016-2021)
13.10.5AlmacGroupRecentDevelopment
13.11SiegfriedHoldingAG
10.11.1SiegfriedHoldingAGCompanyDetails
10.11.2SiegfriedHoldingAGBusinessOverviewandItsTotalRevenue
10.11.3SiegfriedHoldingAGPharmaceuticalContractDevelopmentandManufacturingIntroduction
10.11.4SiegfriedHoldingAGRevenueinPharmaceuticalContractDevelopmentandManufacturingBusiness(2016-2021)
10.11.5SiegfriedHoldingAGRecentDevelopment
13.12BoehringerIngelheimInternationalGmbH
10.12.1BoehringerIngelheimInternationalGmbHCompanyDetails
10.12.2BoehringerIngelheimInternationalGmbHBusinessOverviewandItsTotalRevenue
10.12.3BoehringerIngelheimInternationalGmbHPharmaceuticalContractDevelopmentandManufacturingIntroduction
10.12.4BoehringerIngelheimInternationalGmbHRevenueinPharmaceuticalContractDevelopmentandManufacturingBusiness(2016-2021)
10.12.5BoehringerIngelheimInternationalGmbHRecentDevelopment
13.13EvonikIndustriesAG
10.13.1EvonikIndustriesAGCompanyDetails
10.13.2EvonikIndustriesAGBusinessOverviewandItsTotalRevenue
10.13.3EvonikIndustriesAGPharmaceuticalContractDevelopmentandManufacturingIntroduction
10.13.4EvonikIndustriesAGRevenueinPharmaceuticalContractDevelopmentandManufacturingBusiness(2016-2021)
10.13.5EvonikIndustriesAGRecentDevelopment 14Analyst'sViewpoints/Conclusions 15Appendix
15.1ResearchMethodology
15.1.1Methodology/ResearchApproach
15.1.2DataSource
15.2Disclaimer
15.3AuthorDetails

Pharmaceutical Contract Development and Manufacturing Market Segments


Pharmaceutical Contract Development and Manufacturing Product Type Outlook (Revenue, USD Million, 2021 2027)


  • Pharmaceutical Manufacturing Services
  • Biologics Manufacturing Services
  • Drug Development Services

Pharmaceutical Contract Development and Manufacturing Application Outlook (Revenue, USD Million, 2021 2027)


  • Big Pharma
  • Small Pharma
  • Generic Pharma
  • CRO

Pharmaceutical Contract Development and Manufacturing Regional Outlook (Revenue, USD Million, 2021 2027)


  • North America
    • Pharmaceutical Contract Development and Manufacturing market, By Product Type Outlook
      • Pharmaceutical Manufacturing Services
      • Biologics Manufacturing Services
      • Drug Development Services

    • Pharmaceutical Contract Development and Manufacturing market, By Application Outlook
      • Big Pharma
      • Small Pharma
      • Generic Pharma
      • CRO

  • Europe
    • Pharmaceutical Contract Development and Manufacturing market, By Product Type Outlook
      • Pharmaceutical Manufacturing Services
      • Biologics Manufacturing Services
      • Drug Development Services

    • Pharmaceutical Contract Development and Manufacturing market, By Application Outlook
      • Big Pharma
      • Small Pharma
      • Generic Pharma
      • CRO

  • Asia Pacific
    • Pharmaceutical Contract Development and Manufacturing market, By Product Type Outlook
      • Pharmaceutical Manufacturing Services
      • Biologics Manufacturing Services
      • Drug Development Services

    • Pharmaceutical Contract Development and Manufacturing market, By Application Outlook
      • Big Pharma
      • Small Pharma
      • Generic Pharma
      • CRO

  • Latin America
    • Pharmaceutical Contract Development and Manufacturing market, By Product Type Outlook
      • Pharmaceutical Manufacturing Services
      • Biologics Manufacturing Services
      • Drug Development Services

    • Pharmaceutical Contract Development and Manufacturing market, By Application Outlook
      • Big Pharma
      • Small Pharma
      • Generic Pharma
      • CRO

  • Middle East & Africa
    • Pharmaceutical Contract Development and Manufacturing market, By Product Type Outlook
      • Pharmaceutical Manufacturing Services
      • Biologics Manufacturing Services
      • Drug Development Services

    • Pharmaceutical Contract Development and Manufacturing market, By Application Outlook
      • Big Pharma
      • Small Pharma
      • Generic Pharma
      • CRO

Report Content:


Qualitative Analysis


  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porters analysis
  • PESTEL Analysis
  • Value Chain Analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Overview
    • Financials
    • Product benchmarking
    • Latest strategic developments

Quantitative Analysis


  • Market size, estimates, and forecasts from 2021 - 2027
  • Market revenue estimates for product type up to 2027
  • Market revenue estimates for application type up to 2027
  • Regional market size and forecast up to 2027
  • Company financials
List of Tables
Table 1. Pharmaceutical Contract Development and Manufacturing Key Market Segments
Table 2. Key Players Covered: Ranking by Pharmaceutical Contract Development and Manufacturing Revenue
Table 3. Ranking of Global Top Pharmaceutical Contract Development and Manufacturing Manufacturers by Revenue (US$ Million) in 2020
Table 4. Global Pharmaceutical Contract Development and Manufacturing Market Size Growth Rate by Type (US$ Million): 2021 VS 2027
Table 5. Key Players of Pharmaceutical Manufacturing Services
Table 6. Key Players of Biologics Manufacturing Services
Table 7. Key Players of Drug Development Services
Table 8. Global Pharmaceutical Contract Development and Manufacturing Market Size Growth by Application (US$ Million): 2021 VS 2027
Table 9. Global Pharmaceutical Contract Development and Manufacturing Market Size by Regions (US$ Million): 2021 VS 2027
Table 10. Global Pharmaceutical Contract Development and Manufacturing Market Size by Regions (2016-2021) (US$ Million)
Table 11. Global Pharmaceutical Contract Development and Manufacturing Market Share by Regions (2016-2021)
Table 12. Global Pharmaceutical Contract Development and Manufacturing Forecasted Market Size by Regions (2021-2027) (US$ Million)
Table 13. Global Pharmaceutical Contract Development and Manufacturing Market Share by Regions (2021-2027)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Pharmaceutical Contract Development and Manufacturing Market Growth Strategy
Table 18. Main Points Interviewed from Key Pharmaceutical Contract Development and Manufacturing Players
Table 19. Global Pharmaceutical Contract Development and Manufacturing Revenue by Players (2016-2021) (Million US$)
Table 20. Global Pharmaceutical Contract Development and Manufacturing Market Share by Players (2016-2021)
Table 21. Global Top Pharmaceutical Contract Development and Manufacturing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmaceutical Contract Development and Manufacturing as of 2020)
Table 22. Global Pharmaceutical Contract Development and Manufacturing by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Pharmaceutical Contract Development and Manufacturing Product Solution and Service
Table 25. Date of Enter into Pharmaceutical Contract Development and Manufacturing Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Pharmaceutical Contract Development and Manufacturing Market Size by Type (2016-2021) (Million US$)
Table 28. Global Pharmaceutical Contract Development and Manufacturing Market Size Share by Type (2016-2021)
Table 29. Global Pharmaceutical Contract Development and Manufacturing Revenue Market Share by Type (2021-2027)
Table 30. Global Pharmaceutical Contract Development and Manufacturing Market Size Share by Application (2016-2021)
Table 31. Global Pharmaceutical Contract Development and Manufacturing Market Size by Application (2016-2021) (Million US$)
Table 32. Global Pharmaceutical Contract Development and Manufacturing Market Size Share by Application (2021-2027)
Table 33. North America Key Players Pharmaceutical Contract Development and Manufacturing Revenue (2020-2021) (Million US$)
Table 34. North America Key Players Pharmaceutical Contract Development and Manufacturing Market Share (2020-2021)
Table 35. North America Pharmaceutical Contract Development and Manufacturing Market Size by Type (2016-2021) (Million US$)
Table 36. North America Pharmaceutical Contract Development and Manufacturing Market Share by Type (2016-2021)
Table 37. North America Pharmaceutical Contract Development and Manufacturing Market Size by Application (2016-2021) (Million US$)
Table 38. North America Pharmaceutical Contract Development and Manufacturing Market Share by Application (2016-2021)
Table 39. Europe Key Players Pharmaceutical Contract Development and Manufacturing Revenue (2020-2021) (Million US$)
Table 40. Europe Key Players Pharmaceutical Contract Development and Manufacturing Market Share (2020-2021)
Table 41. Europe Pharmaceutical Contract Development and Manufacturing Market Size by Type (2016-2021) (Million US$)
Table 42. Europe Pharmaceutical Contract Development and Manufacturing Market Share by Type (2016-2021)
Table 43. Europe Pharmaceutical Contract Development and Manufacturing Market Size by Application (2016-2021) (Million US$)
Table 44. Europe Pharmaceutical Contract Development and Manufacturing Market Share by Application (2016-2021)
Table 45. China Key Players Pharmaceutical Contract Development and Manufacturing Revenue (2020-2021) (Million US$)
Table 46. China Key Players Pharmaceutical Contract Development and Manufacturing Market Share (2020-2021)
Table 47. China Pharmaceutical Contract Development and Manufacturing Market Size by Type (2016-2021) (Million US$)
Table 48. China Pharmaceutical Contract Development and Manufacturing Market Share by Type (2016-2021)
Table 49. China Pharmaceutical Contract Development and Manufacturing Market Size by Application (2016-2021) (Million US$)
Table 50. China Pharmaceutical Contract Development and Manufacturing Market Share by Application (2016-2021)
Table 51. Japan Key Players Pharmaceutical Contract Development and Manufacturing Revenue (2020-2021) (Million US$)
Table 52. Japan Key Players Pharmaceutical Contract Development and Manufacturing Market Share (2020-2021)
Table 53. Japan Pharmaceutical Contract Development and Manufacturing Market Size by Type (2016-2021) (Million US$)
Table 54. Japan Pharmaceutical Contract Development and Manufacturing Market Share by Type (2016-2021)
Table 55. Japan Pharmaceutical Contract Development and Manufacturing Market Size by Application (2016-2021) (Million US$)
Table 56. Japan Pharmaceutical Contract Development and Manufacturing Market Share by Application (2016-2021)
Table 57. Southeast Asia Key Players Pharmaceutical Contract Development and Manufacturing Revenue (2020-2021) (Million US$)
Table 58. Southeast Asia Key Players Pharmaceutical Contract Development and Manufacturing Market Share (2020-2021)
Table 59. Southeast Asia Pharmaceutical Contract Development and Manufacturing Market Size by Type (2016-2021) (Million US$)
Table 60. Southeast Asia Pharmaceutical Contract Development and Manufacturing Market Share by Type (2016-2021)
Table 61. Southeast Asia Pharmaceutical Contract Development and Manufacturing Market Size by Application (2016-2021) (Million US$)
Table 62. Southeast Asia Pharmaceutical Contract Development and Manufacturing Market Share by Application (2016-2021)
Table 63. India Key Players Pharmaceutical Contract Development and Manufacturing Revenue (2020-2021) (Million US$)
Table 64. India Key Players Pharmaceutical Contract Development and Manufacturing Market Share (2020-2021)
Table 65. India Pharmaceutical Contract Development and Manufacturing Market Size by Type (2016-2021) (Million US$)
Table 66. India Pharmaceutical Contract Development and Manufacturing Market Share by Type (2016-2021)
Table 67. India Pharmaceutical Contract Development and Manufacturing Market Size by Application (2016-2021) (Million US$)
Table 68. India Pharmaceutical Contract Development and Manufacturing Market Share by Application (2016-2021)
Table 69. Central and South America Key Players Pharmaceutical Contract Development and Manufacturing Revenue (2020-2021) (Million US$)
Table 70. Central and South America Key Players Pharmaceutical Contract Development and Manufacturing Market Share (2020-2021)
Table 71. Central and South America Pharmaceutical Contract Development and Manufacturing Market Size by Type (2016-2021) (Million US$)
Table 72. Central and South America Pharmaceutical Contract Development and Manufacturing Market Share by Type (2016-2021)
Table 73. Central and South America Pharmaceutical Contract Development and Manufacturing Market Size by Application (2016-2021) (Million US$)
Table 74. Central and South America Pharmaceutical Contract Development and Manufacturing Market Share by Application (2016-2021)
Table 75. Thermo Fisher Scientific Inc. Company Details
Table 76. Thermo Fisher Scientific Inc. Business Overview
Table 77. Thermo Fisher Scientific Inc. Product
Table 78. Thermo Fisher Scientific Inc. Revenue in Pharmaceutical Contract Development and Manufacturing Business (2016-2021) (Million US$)
Table 79. Thermo Fisher Scientific Inc. Recent Development
Table 80. Catalent, Inc. Company Details
Table 81. Catalent, Inc. Business Overview
Table 82. Catalent, Inc. Product
Table 83. Catalent, Inc. Revenue in Pharmaceutical Contract Development and Manufacturing Business (2016-2021) (Million US$)
Table 84. Catalent, Inc. Recent Development
Table 85. Lonza Group Ltd Company Details
Table 86. Lonza Group Ltd Business Overview
Table 87. Lonza Group Ltd Product
Table 88. Lonza Group Ltd Revenue in Pharmaceutical Contract Development and Manufacturing Business (2016-2021) (Million US$)
Table 89. Lonza Group Ltd Recent Development
Table 90. Recipharm AB Company Details
Table 91. Recipharm AB Business Overview
Table 92. Recipharm AB Product
Table 93. Recipharm AB Revenue in Pharmaceutical Contract Development and Manufacturing Business (2016-2021) (Million US$)
Table 94. Recipharm AB Recent Development
Table 95. Vetter Pharma International GMBH Company Details
Table 96. Vetter Pharma International GMBH Business Overview
Table 97. Vetter Pharma International GMBH Product
Table 98. Vetter Pharma International GMBH Revenue in Pharmaceutical Contract Development and Manufacturing Business (2016-2021) (Million US$)
Table 99. Vetter Pharma International GMBH Recent Development
Table 100. FAMAR Health Care Services Company Details
Table 101. FAMAR Health Care Services Business Overview
Table 102. FAMAR Health Care Services Product
Table 103. FAMAR Health Care Services Revenue in Pharmaceutical Contract Development and Manufacturing Business (2016-2021) (Million US$)
Table 104. FAMAR Health Care Services Recent Development
Table 105. AbbVie Inc. Company Details
Table 106. AbbVie Inc. Business Overview
Table 107. AbbVie Inc. Product
Table 108. AbbVie Inc. Revenue in Pharmaceutical Contract Development and Manufacturing Business (2016-2021) (Million US$)
Table 109. AbbVie Inc. Recent Development
Table 110. Aenova Group Business Overview
Table 111. Aenova Group Product
Table 112. Aenova Group Company Details
Table 113. Aenova Group Revenue in Pharmaceutical Contract Development and Manufacturing Business (2016-2021) (Million US$)
Table 114. Aenova Group Recent Development
Table 115. Consort Medical plc Company Details
Table 116. Consort Medical plc Business Overview
Table 117. Consort Medical plc Product
Table 118. Consort Medical plc Revenue in Pharmaceutical Contract Development and Manufacturing Business (2016-2021) (Million US$)
Table 119. Consort Medical plc Recent Development
Table 120. Almac Group Company Details
Table 121. Almac Group Business Overview
Table 122. Almac Group Product
Table 123. Almac Group Revenue in Pharmaceutical Contract Development and Manufacturing Business (2016-2021) (Million US$)
Table 124. Almac Group Recent Development
Table 125. Siegfried Holding AG Company Details
Table 126. Siegfried Holding AG Business Overview
Table 127. Siegfried Holding AG Product
Table 128. Siegfried Holding AG Revenue in Pharmaceutical Contract Development and Manufacturing Business (2016-2021) (Million US$)
Table 129. Siegfried Holding AG Recent Development
Table 130. Boehringer Ingelheim International GmbH Company Details
Table 131. Boehringer Ingelheim International GmbH Business Overview
Table 132. Boehringer Ingelheim International GmbH Product
Table 133. Boehringer Ingelheim International GmbH Revenue in Pharmaceutical Contract Development and Manufacturing Business (2016-2021) (Million US$)
Table 134. Boehringer Ingelheim International GmbH Recent Development
Table 135. Evonik Industries AG Company Details
Table 136. Evonik Industries AG Business Overview
Table 137. Evonik Industries AG Product
Table 138. Evonik Industries AG Revenue in Pharmaceutical Contract Development and Manufacturing Business (2016-2021) (Million US$)
Table 139. Evonik Industries AG Recent Development
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pharmaceutical Contract Development and Manufacturing Market Share by Type: 2021 VS 2027
Figure 2. Pharmaceutical Manufacturing Services Features
Figure 3. Biologics Manufacturing Services Features
Figure 4. Drug Development Services Features
Figure 5. Global Pharmaceutical Contract Development and Manufacturing Market Share by Application: 2021 VS 2027
Figure 6. Big Pharma Case Studies
Figure 7. Small Pharma Case Studies
Figure 8. Generic Pharma Case Studies
Figure 9. CRO Case Studies
Figure 10. Pharmaceutical Contract Development and Manufacturing Report Years Considered
Figure 11. Global Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth 2016-2027 (US$ Million)
Figure 12. Global Pharmaceutical Contract Development and Manufacturing Market Share by Regions: 2021 VS 2027
Figure 13. Global Pharmaceutical Contract Development and Manufacturing Market Share by Regions (2021-2027)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Pharmaceutical Contract Development and Manufacturing Market Share by Players in 2020
Figure 16. Global Top Pharmaceutical Contract Development and Manufacturing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmaceutical Contract Development and Manufacturing as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Pharmaceutical Contract Development and Manufacturing Revenue in 2020
Figure 18. North America Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2016-2021) (Million US$)
Figure 19. Europe Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2016-2021) (Million US$)
Figure 20. China Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2016-2021) (Million US$)
Figure 21. Japan Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2016-2021) (Million US$)
Figure 22. Southeast Asia Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2016-2021) (Million US$)
Figure 23. India Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2016-2021) (Million US$)
Figure 24. Central and South America Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2016-2021) (Million US$)
Figure 25. Thermo Fisher Scientific Inc. Total Revenue (US$ Million): 2020 Compared with 2018
Figure 26. Thermo Fisher Scientific Inc. Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2016-2021)
Figure 27. Catalent, Inc. Total Revenue (US$ Million): 2020 Compared with 2018
Figure 28. Catalent, Inc. Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2016-2021)
Figure 29. Lonza Group Ltd Total Revenue (US$ Million): 2020 Compared with 2018
Figure 30. Lonza Group Ltd Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2016-2021)
Figure 31. Recipharm AB Total Revenue (US$ Million): 2020 Compared with 2018
Figure 32. Recipharm AB Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2016-2021)
Figure 33. Vetter Pharma International GMBH Total Revenue (US$ Million): 2020 Compared with 2018
Figure 34. Vetter Pharma International GMBH Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2016-2021)
Figure 35. FAMAR Health Care Services Total Revenue (US$ Million): 2020 Compared with 2018
Figure 36. FAMAR Health Care Services Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2016-2021)
Figure 37. AbbVie Inc. Total Revenue (US$ Million): 2020 Compared with 2018
Figure 38. AbbVie Inc. Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2016-2021)
Figure 39. Aenova Group Total Revenue (US$ Million): 2020 Compared with 2018
Figure 40. Aenova Group Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2016-2021)
Figure 41. Consort Medical plc Total Revenue (US$ Million): 2020 Compared with 2018
Figure 42. Consort Medical plc Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2016-2021)
Figure 43. Almac Group Total Revenue (US$ Million): 2020 Compared with 2018
Figure 44. Almac Group Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2016-2021)
Figure 45. Siegfried Holding AG Total Revenue (US$ Million): 2020 Compared with 2018
Figure 46. Siegfried Holding AG Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2016-2021)
Figure 47. Boehringer Ingelheim International GmbH Total Revenue (US$ Million): 2020 Compared with 2018
Figure 48. Boehringer Ingelheim International GmbH Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2016-2021)
Figure 49. Evonik Industries AG Total Revenue (US$ Million): 2020 Compared with 2018
Figure 50. Evonik Industries AG Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2016-2021)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
Choose License Type
  • $4250  
  • $6250  
  • $8250  

Secure Payment


img1

Related Reports

Protective Eyewear Market

Report Description According to the new market study, we provide a comprehensive and in-depth analys

Read More

Smart Orthopedic Implants Market

Report Description The Global Smart Orthopedic Implants Market Report provides Insightful informatio

Read More

Biotechnology Reagents & Kits Market

Report Description The Global Biotechnology Reagents & Kits Market Report provides Insightful inform

Read More